Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -2.354% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) COc1ccc(-c2sc(NC(C)=O)nc2-c2ccccc2)cc1
b.) CSc1ccccc1NC(=O)CSc1nnc(Cc2ccccc2)o1
c.) CSCC[C@H](NC(=O)N1CCn2c1nc1ccccc12)C(=O)N[C@@H](C(=O)O)c1ccccc1
Answer: b. CSc1ccccc1NC(=O)CSc1nnc(Cc2ccccc2)o1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSc1ccccc1NC(=O)CSc1nnc(Cc2ccccc2)o1
CSc1ccccc1NC(=O)CSc1nnc(Cc2ccccc2)o1
2-[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]-N-(2-methylsulfanylphenyl)acetamide